Amarex Clinical Research: Amarex Client Receives U.S. FDA Marketing Approval for Hemoconcentrators

Amarex leveraged knowledge gleaned from past FDA applications to finish 510(k) studies and application in five months, leading to rapid clearance. GERMANTOWN, MD, UNITED STATES, March 11, 2024 /⁨EINPresswire.com⁩/ -- Amarex Clinical Research, LLC, an NSF ...